60 Degrees Pharmaceuticals Inc (NASDAQ:SXTP) currently has a daily average trading volume of 2.47M but it saw 797329 shares traded in last market. With a market cap of 3.48M USD, the company’s current market price of $0.47 came falling about -10.92 while comparing to the previous closing price of $0.53. In past 52 weeks, the stock remained buoying in the range of price level as high as $7.20 and as low as $0.45.
Taking a look at 20-day trading activity of 60 Degrees Pharmaceuticals Inc (SXTP) gives us an average price of $0.6713, while its current price level is -93.44% below from 52-week high level whereas it is 4.75% above from lowest level seen by the stock during that period. Simple moving average of 50 days or SMA-50 of the stock’s closing price is $1.0303 while that of 200 days or SMA-200 reads an average of $1.7107. A closer look into the stock’s movement over the week reveals that its volatility is standing at 15.33% during that period while stretching the period over a month that increases to 18.74%. It is also necessary to take a look into other indicators of a stock too, to get a better idea about its price movement. And in doing so, we find stock’s 14-day relative strength index (RSI) standing at 33.92 which implies that the stock is in neutral territory.
Over the week, SXTP’s stock price is moving -26.82% down while it is -44.29% when we observe its performance for the past one month. Year-to-date it is -63.38% down and over the past year, the stock is showing a downside performance of -87.81%.
The company is expected to be releasing its next quarterly report in March, for which analysts forecasted an EPS of -0.65 while estimate for next year EPS is -5.68. In next quarter, company is expected to be making quarterly sales of $300k as analysts are expecting the sales for current fiscal year at $622.5k and seeing the company making $1.65M in sales next year. Moreover, analysts are in estimates of $234k for current-quarter revenue.
Currently, 60 Degrees Pharmaceuticals Inc’s total number of outstanding shares is 1.86M with 5.45% of that held by the insiders while 2.09% of its common stock has been owned by the institutions. Company’s return on investment (ROI) stands at -132.63% and return on equity (ROE) at -124.71%. Stock’s beta reads 4.23. Stock has a price to sale or P/S ratio amounts to 7.57. Its return on asset (ROA) is -94.78% on average.
